FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311601772> ?p ?o ?g. }

• W4311601772 abstract "Abstract Background Antimicrobial resistance is an important cause of morbidity and mortality globally; low- and middle-income countries (LMICs) face an especially high burden. Ineffective antimicrobial prescriptions and use of broad-spectrum agents contribute to resistance. We describe antibacterial prescribing patterns in patients with febrile illnesses and bloodstream infections (BSI) in northern Tanzania. Methods We compared data from two hospital-based prospective cohort studies, cohort 1 (2011-2014) and cohort 2 (2016-2019), both enrolled febrile pediatric and adult inpatients in Moshi, Tanzania. Aerobic blood culture was obtained in all patients and standard methods were used to determine isolate antimicrobial susceptibility. To describe management of febrile illness, we analyzed antibacterial drug prescription prior to and after enrollment. Broad-spectrum antibacterials were categorized using published frameworks. Treatments were categorized as discordant if a blood culture isolate was not susceptible to the patient’s antibacterial regimen. We performed descriptive statistics and logistic regression to understand predictors of receiving an antibacterial. Results In total, 2,176 febrile inpatients were enrolled. Antibacterials were administered to 430 (42.0%) and 501 (45.1%) patients prior to enrollment, and 930 (89.1%) and 1,060 (93.6%) during admission in cohorts 1 and 2, respectively. Infancy and duration of fever were associated with higher antibacterial prescribing prior to enrollment (Table 2). Broad-spectrum antibacterials were administered to 548 (52.5%) in cohort 1 and 682 (60.2%) in cohort 2. Laboratory-confirmed bacteremia was detected in 87 (4%) patients. Susceptibility results were available in 73 patients; of these, 41 (56.2%) received discordant antibacterials. Conclusion Antibacterials were commonly administered for febrile illness in outpatient and inpatient settings; over half of patients received broad-spectrum antibacterials. A high proportion of patients with culture-positive BSI were treated with ineffective antimicrobials. Improved laboratory diagnostics for febrile illness, antimicrobial stewardship interventions, context-specific clinical guidelines, and provider education may improve prescribing practices. Disclosures Julian Hertz, MD, Roche Diagnostics: Grant/Research Support." @default.
• W4311601772 created "2022-12-27" @default.
• W4311601772 creator A5012938037 @default.
• W4311601772 creator A5014705449 @default.
• W4311601772 creator A5026439623 @default.
• W4311601772 creator A5026459900 @default.
• W4311601772 creator A5031837511 @default.
• W4311601772 creator A5039134813 @default.
• W4311601772 creator A5041784125 @default.
• W4311601772 creator A5043986241 @default.
• W4311601772 creator A5044548124 @default.
• W4311601772 creator A5048912205 @default.
• W4311601772 creator A5056212709 @default.
• W4311601772 creator A5062337176 @default.
• W4311601772 creator A5074553225 @default.
• W4311601772 creator A5076091226 @default.
• W4311601772 creator A5077219377 @default.
• W4311601772 creator A5088607282 @default.
• W4311601772 creator A5089767596 @default.
• W4311601772 date "2022-12-01" @default.
• W4311601772 modified "2023-10-14" @default.
• W4311601772 title "1164. Antibacterial Utilization for Febrile Illnesses and Laboratory-Confirmed Bloodstream Infections in Northern Tanzania" @default.
• W4311601772 doi "https://doi.org/10.1093/ofid/ofac492.1001" @default.
• W4311601772 hasPublicationYear "2022" @default.
• W4311601772 type Work @default.
• W4311601772 citedByCount "0" @default.
• W4311601772 crossrefType "journal-article" @default.
• W4311601772 hasAuthorship W4311601772A5012938037 @default.
• W4311601772 hasAuthorship W4311601772A5014705449 @default.
• W4311601772 hasAuthorship W4311601772A5026439623 @default.
• W4311601772 hasAuthorship W4311601772A5026459900 @default.
• W4311601772 hasAuthorship W4311601772A5031837511 @default.
• W4311601772 hasAuthorship W4311601772A5039134813 @default.
• W4311601772 hasAuthorship W4311601772A5041784125 @default.
• W4311601772 hasAuthorship W4311601772A5043986241 @default.
• W4311601772 hasAuthorship W4311601772A5044548124 @default.
• W4311601772 hasAuthorship W4311601772A5048912205 @default.
• W4311601772 hasAuthorship W4311601772A5056212709 @default.
• W4311601772 hasAuthorship W4311601772A5062337176 @default.
• W4311601772 hasAuthorship W4311601772A5074553225 @default.
• W4311601772 hasAuthorship W4311601772A5076091226 @default.
• W4311601772 hasAuthorship W4311601772A5077219377 @default.
• W4311601772 hasAuthorship W4311601772A5088607282 @default.
• W4311601772 hasAuthorship W4311601772A5089767596 @default.
• W4311601772 hasBestOaLocation W43116017721 @default.
• W4311601772 hasConcept C126322002 @default.
• W4311601772 hasConcept C151956035 @default.
• W4311601772 hasConcept C187212893 @default.
• W4311601772 hasConcept C188816634 @default.
• W4311601772 hasConcept C201903717 @default.
• W4311601772 hasConcept C2426938 @default.
• W4311601772 hasConcept C2779357621 @default.
• W4311601772 hasConcept C2779443120 @default.
• W4311601772 hasConcept C2779473907 @default.
• W4311601772 hasConcept C2781413609 @default.
• W4311601772 hasConcept C39432304 @default.
• W4311601772 hasConcept C4937899 @default.
• W4311601772 hasConcept C501593827 @default.
• W4311601772 hasConcept C71924100 @default.
• W4311601772 hasConcept C72563966 @default.
• W4311601772 hasConcept C86803240 @default.
• W4311601772 hasConcept C89423630 @default.
• W4311601772 hasConcept C91375879 @default.
• W4311601772 hasConcept C94665300 @default.
• W4311601772 hasConcept C98274493 @default.
• W4311601772 hasConceptScore W4311601772C126322002 @default.
• W4311601772 hasConceptScore W4311601772C151956035 @default.
• W4311601772 hasConceptScore W4311601772C187212893 @default.
• W4311601772 hasConceptScore W4311601772C188816634 @default.
• W4311601772 hasConceptScore W4311601772C201903717 @default.
• W4311601772 hasConceptScore W4311601772C2426938 @default.
• W4311601772 hasConceptScore W4311601772C2779357621 @default.
• W4311601772 hasConceptScore W4311601772C2779443120 @default.
• W4311601772 hasConceptScore W4311601772C2779473907 @default.
• W4311601772 hasConceptScore W4311601772C2781413609 @default.
• W4311601772 hasConceptScore W4311601772C39432304 @default.
• W4311601772 hasConceptScore W4311601772C4937899 @default.
• W4311601772 hasConceptScore W4311601772C501593827 @default.
• W4311601772 hasConceptScore W4311601772C71924100 @default.
• W4311601772 hasConceptScore W4311601772C72563966 @default.
• W4311601772 hasConceptScore W4311601772C86803240 @default.
• W4311601772 hasConceptScore W4311601772C89423630 @default.
• W4311601772 hasConceptScore W4311601772C91375879 @default.
• W4311601772 hasConceptScore W4311601772C94665300 @default.
• W4311601772 hasConceptScore W4311601772C98274493 @default.
• W4311601772 hasIssue "Supplement_2" @default.
• W4311601772 hasLocation W43116017721 @default.
• W4311601772 hasLocation W43116017722 @default.
• W4311601772 hasOpenAccess W4311601772 @default.
• W4311601772 hasPrimaryLocation W43116017721 @default.
• W4311601772 hasRelatedWork W2000402391 @default.
• W4311601772 hasRelatedWork W2034451974 @default.
• W4311601772 hasRelatedWork W2274212671 @default.
• W4311601772 hasRelatedWork W2318509744 @default.
• W4311601772 hasRelatedWork W2387180541 @default.
• W4311601772 hasRelatedWork W2907284219 @default.
• W4311601772 hasRelatedWork W3128949511 @default.
• W4311601772 hasRelatedWork W3129287770 @default.
• W4311601772 hasRelatedWork W4315473050 @default.
• W4311601772 hasRelatedWork W2292265946 @default.

• next